Sign in

You're signed outSign in or to get full access.

CR

Clipper Realty Inc. (CLPR)·Q2 2025 Earnings Summary

Executive Summary

  • Q2 2025 revenue was $39.0M (+4.5% YoY; -0.9% QoQ), with record NOI of $22.1M and record AFFO of $8.3M; diluted EPS was -$0.07. Management cited strong residential leasing, with new leases ~14% above prior rents and renewals >6% .
  • Dividend maintained at $0.095 per share; liquidity supported by $32.0M unrestricted cash and $28.8M restricted cash, 88% of operating debt fixed at 3.87% average rate and 4.1-year duration .
  • Dean Street (Prospect House) construction completed; leasing commenced (33% leased at $88/sf), and a $160M bridge loan (SOFR+2.65%) was closed to fund carry and working capital; NYC to vacate 250 Livingston at month-end while a five-year renewal at 141 Livingston is being processed .
  • Versus S&P consensus, revenue was essentially in-line, but EBITDA missed: Q2 revenue $39.04M vs $39.10M estimate; EBITDA $18.23M vs $19.90M estimate; with only one covering estimate, adjustments may be limited in scope. Values retrieved from S&P Global.*

What Went Well and What Went Wrong

What Went Well

  • Residential leasing strength drove near-record revenue; “new leases exceeded previous rents by nearly 14% and renewals by over 6%,” and occupancy remained high across the portfolio .
  • Record NOI ($22.1M) and record AFFO ($8.3M), supported by higher rents and occupancy and lower utilities, despite certain Flatbush costs and modest tax/insurance increases .
  • Prospect House completed on time/on budget; leasing underway at $88/sf; the $160M bridge loan lowers interest (SOFR+2.65%), funds operating costs through lease-up, and provides working capital .

What Went Wrong

  • Office headwind: NYC vacating 250 Livingston at month-end; historically the property generated ~$4.6M quarterly revenue, ~$1.7M operating expenses, and ~$1.2M interest expense—creating near-term revenue/NOI risk .
  • Flatbush Gardens expense pressure: higher payroll/repairs and maintenance and other operating expenses lifted property operating costs YoY; bad debt also rose modestly .
  • EBITDA missed S&P consensus by ~$1.7M; despite strong rents/occupancy, higher property-level expenses (notably at Flatbush) and disposal-related costs weighed on profitability. Values retrieved from S&P Global.*

Financial Results

Core P&L and Margin Trends (sequential and vs consensus)

MetricQ4 2024Q1 2025Q2 2025Q2 2025 Consensus
Revenue ($USD Millions)$38.047 $39.398 $39.036 $39.100*
Diluted EPS ($)-$0.05 -$0.86 -$0.07 N/A (unavailable)*
EBITDA ($USD Millions)$19.497*$19.120*$18.234*$19.900*
EBITDA Margin (%)51.3%*48.5%*46.7%*N/A*

Values retrieved from S&P Global.*

YoY Comparison (Q2 2024 vs Q2 2025)

MetricQ2 2024Q2 2025
Revenue ($USD Millions)$37.346 $39.036
Diluted EPS ($)-$0.06 -$0.07
NOI ($USD Millions)$21.071 $22.115
AFFO ($USD Millions)$7.053 $8.318
AFFO per share ($)$0.17 $0.20

Segment Revenue Breakdown (sequential)

Segment Revenue ($USD Millions)Q4 2024Q1 2025Q2 2025
Residential Rental Income$28.173 $29.190 $29.054
Commercial Rental Income$9.874 $10.208 $9.982
Total Revenues$38.047 $39.398 $39.036

KPIs (Q2 2025)

KPIQ2 2025
New leases vs prior rents (portfolio)+14%
Renewals (portfolio)+>6%
Collection rate (residential portfolio)~97%
Flatbush Gardens collection rate~95%
Tribeca House occupancy100%
Tribeca House rent per foot (overall/new)>$86 / ~$93
Clover House occupancy98%
Clover House rent per foot (overall/new)~$88 / ~$96
Pacific House occupancy96%
Pacific House new free market rent per foot~$82
Prospect House (Dean Street) leasing~33% leased at ~$88/sf gross

Guidance Changes

MetricPeriodPrevious GuidanceCurrent GuidanceChange
Dividend per shareQ2 2025$0.095 $0.095 Maintained
141 Livingston lease5-year termIn discussions Agreed renewal; lender consent/technical issue in process Progressed
250 Livingston occupancyLate Aug 2025NYC to vacate in late Aug 2025 NYC vacating at month-end; seeking solutions/lender discussions Confirmed timeline

No formal numerical guidance ranges (revenue, NOI, margins, tax rate, OpEx, OI&E, segment-specific) were provided in Q2 materials .

Earnings Call Themes & Trends

TopicPrevious Mentions (Q4 2024, Q1 2025)Current Period (Q2 2025)Trend
Residential leasing strengthNew leases +10% QoQ; high occupancy New leases +~14%; renewals >6%; record rents; near-full occupancy Strengthening
Article 11 / Flatbush GardensEnhanced rental recoveries; higher payroll from prevailing wage Increased rental recoveries under Section 610; continued capital improvements; higher OpEx and payroll Ongoing execution; cost pressure persists
Office exposure (NYC tenancy)250 Livingston: NYC intends to vacate late Aug 2025; 141 Livingston renewal discussions 250 Livingston vacating at month-end; 141 Livingston five-year renewal agreed pending lender consent Transition risk at 250; mitigation via 141 renewal
Development (Dean Street/Pacific House)Dean Street nearing completion; bridge financing arranged; Pacific stabilized Dean Street completed; leasing started; $160M bridge (SOFR+2.65%); Pacific contributing cash flow Executing to plan; leasing underway
Balance sheet/financingDraws on construction loan; dividend maintained Cash $32.0M (unrestricted) and $28.8M (restricted); 88% fixed debt at 3.87% avg; dividend maintained Liquidity stable; interest profile favorable

Management Commentary

  • “For the quarter, the Company continued to maintain revenue, NOI and AFFO at a very high level based on very strong residential leasing… new leases exceeded previous rents by nearly 14% and renewals by over 6%.” — David Bistricer, CEO .
  • “We also look forward to leasing the 953 Dean Street Prospect House development, finalizing the 141 Livingston Street lease, resolving the 250 Livingston Street upcoming vacancy and capitalizing on other possibilities.” — Lawrence Kreider, CFO .
  • CFO highlighted operating leverage and constraints: property operating expenses increased $1.5M YoY (largely at Flatbush), while interest expense decreased $262K YoY due to asset sale and slightly lower variable rates .
  • Liquidity/interest profile: $32.0M unrestricted cash; 88% fixed operating debt at 3.87% average rate and ~4.1-year duration; nonrecourse, asset-level financing .

Q&A Highlights

  • The call ended without audience Q&A; no additional clarifications beyond prepared remarks were provided .

Estimates Context

MetricQ2 2025 ActualQ2 2025 ConsensusSurprise
Revenue ($USD Millions)$39.036 $39.100*-$0.064M (in-line/soft miss)*
EBITDA ($USD Millions)$18.234*$19.900*-$1.666M (miss)*
Revenue – # of EstimatesN/A1*N/A*
EPS (Primary)-$0.07 Unavailable*N/A*

Values retrieved from S&P Global.*

Given the single-estimate coverage and the modest revenue delta, revisions may be limited; EBITDA consensus may need modest downward adjustment to reflect Flatbush-related OpEx and disposal costs that affected Q2 profitability .

Key Takeaways for Investors

  • Residential fundamentals remain robust: double-digit new lease uplift and record rents should support NOI/AFFO into H2, mitigating near-term office vacancy headwinds .
  • Near-term risk at 250 Livingston as NYC vacates; historic ~$4.6M quarterly revenue loss is material; watch for lender negotiations and backfill/conversion plans to limit cash flow drag .
  • Dean Street (Prospect House) leasing ramp is a critical catalyst; bridge financing reduces carry costs and funds working capital, enabling rapid stabilization if demand persists .
  • Liquidity and debt structure are favorable (88% fixed at 3.87% avg; nonrecourse), providing resilience against rate volatility while supporting capex and leasing initiatives .
  • Dividend held at $0.095; sustainability hinges on maintaining AFFO trajectory as development stabilizes and office exposure is addressed .
  • Watch cost discipline at Flatbush Gardens: higher payroll and operating costs weighed on margins; continued Article 11 recoveries and capital upgrades should help, but expense management remains a focus .
  • Minor discrepancy: management references an “impairment charge of ~$0.7M” in Q2 narrative, but statements show a $0.685M loss on disposal and no impairment line item—interpretation likely relates to sale-related costs; rely on GAAP tables for clarity .